This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance. Since the beginning of the year, the Nasdaq 4.9%, the Dow is up 10%, and the S&P is up 7.7%.
Since January 1, Lions Gate Entertainment (NYSE:LGF) has jumped 48.4%. Lions Gate Entertainment develops, produces, and distributes filmed entertainment content. For more information, get Portfolio Grader’s complete analysis of LGF stock.
Since January 1, DXP Enterprises (NASDAQ:DXPE) has climbed 50.8%. DXP Enterprises is engaged in the business of distributing maintenance, repair and operating products, equipment and service to industrial customers. For more information, get Portfolio Grader’s complete analysis of DXPE stock.
Shares of Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB) have risen 53.2% since January 1. Grupo Aeroportuario del Centro Norte operates international airports in the northern and central regions of Mexico. The stock’s trailing PE Ratio is 2.40. For more information, get Portfolio Grader’s complete analysis of OMAB stock.
Since January 1, the price of H&R Block (NYSE:HRB) has grown 53.8%. H&R Block provides a wide range of financial products and services through its subsidiaries. For more information, get Portfolio Grader’s complete analysis of HRB stock.
The price of Virtus Investment Partners (NASDAQ:VRTS) has seen a 60.8% boost since the first of the year. Virtus Investment Partners provides investment management products and services to individuals and institutions in the United States. For more information, get Portfolio Grader’s complete analysis of VRTS stock.
LinkedIn (NYSE:LNKD) has risen 62.5% since the first of the year. LinkedIn operates a social networking website used for professional networking. For more information, get Portfolio Grader’s complete analysis of LNKD stock.
Since January 1, Santarus (NASDAQ:SNTS) has shot up 63.4%. Santarus, Inc. was incorporated in California in December 1996 and reincorporated in Delaware in July 2002. It is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians. For more information, get Portfolio Grader’s complete analysis of SNTS stock.
Since the first of the year, the price of China Biologic Products (NASDAQ:CBPO) has swelled 71.2%. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.
Since the first of the year, shares of Lin TV (NYSE:TVL) have soared 72.4%. LIN TV operates various television stations and provides management and sales services to other stations. For more information, get Portfolio Grader’s complete analysis of TVL stock.
The price of Himax Technologies (NASDAQ:HIMX) is up 145.8% since the first of the year. Himax Technologies designs and manufactures integrated circuits. For more information, get Portfolio Grader’s complete analysis of HIMX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
